This failure was foreseeable, as it will be next time.
Marketing evolves in markets--a disaster for science. Competition for jobs, grants and investors rewards deception of self and others. Innovators win by overselling
HT @HeatherEHeying https://www.technologyreview.com/the-download/611659/turns-out-crispr-editing-can-also-vandalize-genomes/?utm_campaign=social_button&utm_source=twitter&utm_medium=social&utm_content=2018-07-17 … via @techreview
-
Silly argument. CRISPR for gene therapy was never going to happen. There are many, many other uses of CRISPR.
-
-
Why so?
-
Sorry, that was meant to be how so? By which I mean are you saying there aren't other uses of CRISPR besides gene therapy?
-
It's been oversold across the board, which is not to say it isn't remarkable.
-
Unless you know the extent to which it can be utilised in biotech and research it is impossible to know whether it is oversold.
End of conversation
New conversation -
-
-
And this is what the hubris sounds like.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.